Cycling hypoxia up-regulates thioredoxin levels in human MDA-MB-231 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 350-355

  Karlenius, Therese C ^a   Shah, Fenil ^a   Di Trapani, Giovanna ^a   Clarke, Frank M ^a   Tonissen, Kathryn F ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Breast cancer cells; Hypoxia; Reactive oxygen species; Reoxygenation; Thioredoxin

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; THIOREDOXIN; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CELL GROWTH; CELL HYPOXIA; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; REPORTER GENE; TUMOR MICROENVIRONMENT; UPREGULATION;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OXYGEN; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; THIOREDOXINS; UP-REGULATION;

EID: 84857997426     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.027     Document Type: Article

References (25)

1. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267:6102-6109.
2. Kim Y.C., Masutani H., Yamaguchi Y., et al. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 2001, 276:18399-18406.
3. Taniguchi Y., Taniguchi-Ueda Y., Mori K., et al. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 1996, 24:2746-2752.
4. Hirota K., Murata M., Sachi Y., et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 1999, 274:27891-27897.
5. Matthews J.R., Wakasugi N., Virelizier J.L., et al. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 1992, 20:3821-3830.
6. Ceccarelli J., Delfino L., Zappia E., et al. The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. Int. J. Cancer 2008, 123:1770-1778.
7. Chaiswing L., Bourdeau-Heller J.M., Zhong W., et al. Characterization of redox state of two human prostate carcinoma cell lines with different degrees of aggressiveness. Free Radical Biol. Med. 2007, 43:202-215.
8. Lincoln D.T., Ali Emadi E.M., Tonissen K.F., et al. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 2003, 23:2425-2433.
9. Kim S.J., Miyoshi Y., Taguchi T., et al. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin. Cancer Res. 2005, 11:8425-8430.
10. Sasada T., Iwata S., Sato N., et al. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 1996, 97:2268-2276.
11. Jones D.T., Pugh C.W., Wigfield S., et al. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation. Clin. Cancer Res. 2006, 12:5384-5394.
12. Welsh S.J., Bellamy W.T., Briehl M.M., et al. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 2002, 62:5089-5095.
13. Brahimi-Horn C., Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull. Cancer 2006, 93:E73-80.
14. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971, 285:1182-1186.
15. Lanzen J., Braun R.D., Klitzman B., et al. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res. 2006, 66:2219-2223.
16. Nehmeh S.A., Lee N.Y., Schroder H., et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:235-242.
17. Yuan G., Nanduri J., Bhasker C.R., et al. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J. Biol. Chem. 2005, 280:4321-4328.
18. Turoczi T., Chang V.W., Engelman R.M., et al. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J. Mol. Cell. Cardiol. 2003, 35:695-704.
19. Karlenius T.C., Shah F., Yu W.C., et al. The selenium content of cell culture serum influences redox-regulated gene expression. Biotechniques 2011, 50:295-301.
20. Osborne S.A., Hawkes H.J., Baldwin B.L., et al. The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochem. J. 2006, 398:269-277.
21. Chen X.L., Varner S.E., Rao A.S., et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J. Biol. Chem. 2003, 278:703-711.
22. Ema M., Hirota K., Mimura J., et al. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 1999, 18:1905-1914.
23. Berggren M., Gallegos A., Gasdaska J.R., et al. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res. 1996, 16:3459-3466.
24. Kim Y.J., Ahn J.Y., Liang P., et al. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res. 2007, 67:546-554.
25. Farina A.R., Cappabianca L., DeSantis G., et al. Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. FEBS Lett. 2011, 585:3328-3336.